Pierre Tennstedt
Thrombospondin 1 and cathepsin D improve prostate cancer diagnosis by avoiding potentially unneeded prostate biopsies
Steuber T, Tennstedt P, Macagno A, Athanasiou A, Wittig A, Huber R, Golding B, Schiess R, Gillessen Sommer S. Thrombospondin 1 and cathepsin D improve prostate cancer diagnosis by avoiding potentially unneeded prostate biopsies. BJU Int 2018
Sep 14, 2018Thrombospondin 1 and cathepsin D improve prostate cancer diagnosis by avoiding potentially unneeded prostate biopsies
Sep 14, 2018BJU Int 2018
Steuber Thomas, Tennstedt Pierre, Macagno Annalisa, Athanasiou Alcibiade, Wittig Anja, Huber Ramy, Golding Bruno, Schiess Ralph, Gillessen Sommer Silke
Development and clinical testing of individual immunoassays for the quantification of serum glycoproteins to diagnose prostate cancer
Endt K, Joos T, Gillessen Sommer S, Steuber T, Engeler D, Rainisio M, Guenther A, Tennstedt P, Athanasiou A, Omlin A, Goepfert J, Schiess R. Development and clinical testing of individual immunoassays for the quantification of serum glycoproteins to diagnose prostate cancer. PloS one 2017; 12:e0181557.
Aug 2, 2017Development and clinical testing of individual immunoassays for the quantification of serum glycoproteins to diagnose prostate cancer
Aug 2, 2017PloS one 2017; 12:e0181557
Endt Kathrin, Joos Thomas, Gillessen Sommer Silke, Steuber Thomas, Engeler Daniel, Rainisio Maurizio, Guenther Anna, Tennstedt Pierre, Athanasiou Alcibiade, Omlin Aurelius, Goepfert Jens, Schiess Ralph